TrademarkDir
GANLEEPEN
LIVE

Serial Number

97201790

Owner

Gan & Lee Pharmaceuticals.

Attorney

Nazly Aileen Bayramoglu

Filing Date

Jan 4, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GANLEEPEN Trademark

Serial Number: 97201790 • Registration: 7390197

GANLEEPEN is a trademark filed by Gan & Lee Pharmaceuticals. on January 4, 2022. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Gan & Lee Pharmaceuticals. (13 trademarks)

No. 8 Jingsheng North 3rd Street,

Entity Type: 98

Trademark Details

Filing Date

January 4, 2022

Registration Date

May 21, 2024

Published for Opposition

January 2, 2024

Goods & Services

Apparatus for blood analysis; Apparatus for DNA and RNA testing for medical purposes; Hypodermic syringes; Lancets; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical diagnostic apparatus for testing blood sugar levels; Needles for medical purposes; Syringes for injections; Syringes for medical purposes; Vacuum pumps for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 21, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 21, 2024 R.PR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 16, 2024 ERRR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 24, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2023 CRFA
ASSIGNED TO LIE
Nov 2, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 1, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 27, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 27, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 27, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 20, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 13, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 13, 2022 GNSL
SUSPENSION LETTER WRITTEN
Oct 13, 2022 CNSL
ASSIGNED TO EXAMINER
Oct 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2022 NWOS
NEW APPLICATION ENTERED
Jan 7, 2022 NWAP

Related Trademarks

More from this Owner

ELASPEN

ELASPEN

INSTAPEN

INSTAPEN

ELASPEN

ELASPEN

ELASPEN

ELASPEN

INSTAPEN

INSTAPEN

INSTANLIN

INSTANLIN